loading page

Brunsting-Perry Pemphigoid Successfully Treated with Intralesional Rituximab
  • Icim Komurcugil,
  • Nermin Karaosmanoglu,
  • Ibrahim Emre Bulut
Icim Komurcugil
Ankara Eğitim Ve Araştırma Hastanesi

Corresponding Author:[email protected]

Author Profile
Nermin Karaosmanoglu
Ankara Training and Research Hospital
Author Profile
Ibrahim Emre Bulut
Ankara Training and Research Hospital
Author Profile

Abstract

Brunsting-Perry pemphigoid (BPP) is a variant of cicatricial pemphigoid characterised by tense, pruritic subepidermal bullae which eventually heals with atophic scarring. BPP has a predilection for head and neck area with little or no mucosal involvement. Average age of onset is 58 with a 2:1 male/female ratio. Here, we report a
23 Aug 2023Submitted to Clinical Case Reports
25 Aug 2023Submission Checks Completed
25 Aug 2023Assigned to Editor
27 Aug 2023Reviewer(s) Assigned
09 Oct 2023Review(s) Completed, Editorial Evaluation Pending
09 Oct 2023Editorial Decision: Revise Minor